SC 13D/A

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 8)*

 

 

Acucela Inc.

(Name of Issuer)

Common Stock, no par value

(Title of Class of Securities)

00510T 109

(CUSIP Number)

Masashi Okuyama

Legal & Compliance Dept. of SBI Holdings, Inc.

SBI Holdings, Inc.

Izumi Garden Tower 19F, 1-6-1 Roppongi, Minato-ku, Tokyo 106-6019, Japan

+81-3-6229-0122

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

November 26, 2015

(Date of Event Which Requires Filing of This Statement)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g) check the following box:  ¨

 

 

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

 

 

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


SCHEDULE 13D

 

CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Holdings, Inc.

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

    7,752,425

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    7,752,425

11  

Aggregate amount beneficially owned by each reporting person

 

    7,752,425

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    21.2% (1)

14  

Type of reporting person

 

    CO (Corporation organized in Japan)

 

(1) The calculations set forth in Row (13) for each Reporting Person are based on 36,503,120 shares of Common Stock, no par value, outstanding as of October 30, 2015, as reported on the Form 10-Q for the fiscal quarter ended September 30, 2015, filed by the Issuer with the Securities and Exchange Commission on November 13, 2015.


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Capital Management Co., Ltd.

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

    6,196,869

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    6,196,869

11  

Aggregate amount beneficially owned by each reporting person

 

    6,196,869

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    17.0%

14  

Type of reporting person

 

    CO (Corporation organized in Japan)

 


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Investment Co., Ltd.

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

    4,160,115

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    4,160,115

11  

Aggregate amount beneficially owned by each reporting person

 

    4,160,115

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    11.4%

14  

Type of reporting person

 

    CO (Corporation organized in Japan)

 


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Incubation Co., Ltd.

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

    1,555,556

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    1,555,556

11  

Aggregate amount beneficially owned by each reporting person

 

    1,555,556

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    4.3%

14  

Type of reporting person

 

    CO (Corporation organized in Japan)

 


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

Trans-Science No. 2A Investment Limited Partnership

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

    -0-

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    -0-

11  

Aggregate amount beneficially owned by each reporting person

 

    -0-

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    0.00%

14  

Type of reporting person

 

    PN (Limited partnership organized in Japan)

 


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Transscience Co., Ltd.

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

    -0-

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    -0-

11  

Aggregate amount beneficially owned by each reporting person

 

    -0-

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    0.00%

14  

Type of reporting person

 

    CO (Corporation organized in Japan)

 


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

BIOVISION Life Science Fund No. 1

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

    1,777,778

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    1,777,778

11  

Aggregate amount beneficially owned by each reporting person

 

    1,777,778

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    4.9%

14  

Type of reporting person

 

    PN (Limited partnership organized in Japan)

 


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Bio Life Science Investment LPS

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

    1,871,250

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    1,871,250

11  

Aggregate amount beneficially owned by each reporting person

 

    1,871,250

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    5.1%

14  

Type of reporting person

 

    PN (Limited partnership organized in Japan)

 


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI BB Mobile Investment LPS

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

     258,582

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    258,582

11  

Aggregate amount beneficially owned by each reporting person

 

    258,582

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    0.7%

14  

Type of reporting person

 

    PN (Limited partnership organized in Japan)

 


CUSIP No. 00510T 109  

 

  1   

Name of reporting person:

 

SBI Phoenix No. 1 Investment LPS

  2  

Check the appropriate box if a member of a group

(a)  x        (b)  ¨

Please see response to Item 5

  3  

SEC use only

 

  4  

Source of funds

 

    OO

  5  

Check box if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)    ¨

 

  6  

Citizenship or place of organization

 

    Japan

Number of

shares

beneficially

owned by

each

reporting

person

with

 

     7    

Sole voting power

 

    -0-

     8   

Shared voting power

 

    252,505

     9   

Sole dispositive power

 

    -0-

   10   

Shared dispositive power

 

    252,505

11  

Aggregate amount beneficially owned by each reporting person

 

    252,505

12  

Check box if the aggregate amount in Row (11) excludes certain shares    ¨

 

13  

Percent of class represented by amount in Row (11)

 

    0.7%

14  

Type of reporting person

 

    PN (Limited partnership organized in Japan)

 


SCHEDULE 13D

Acucela Inc.

EXPLANATORY NOTE

The Statement on Schedule 13D originally filed by the persons named therein with the Securities and Exchange Commission on February 20, 2014, as amended by Amendment No. 1 dated September 30, 2014 and filed October 10, 2014; Amendment No. 2 dated January 28, 2015 and filed January 30, 2015; Amendment No. 3 dated March 2, 2015 and filed March 3, 2015; Amendment No. 4 dated March 13, 2015 and filed March 17, 2015; Amendment No. 5 dated March 31, 2015 and filed April 3, 2015; Amendment No. 6 dated and filed April 8, 2015; and Amendment No. 7 dated May 1, 2015 and filed May 14, 2015 (as so amended, the “Statement”), is hereby amended with respect to the items set forth below by this Amendment No. 8 (this “Amendment”). Capitalized terms used herein and not otherwise defined have the meanings assigned to such terms in the Statement. Except as otherwise provided herein, each Item of the Statement remains unchanged.

 

Item 2. Identity and Background.

Item 2 of the Statement is hereby deleted and replaced with the following:

“Each of the following is hereinafter individually referred to as a “Reporting Person” and collectively as the “Reporting Persons.” This Statement is filed on behalf of:

SBI Holdings, Inc.

SBI Capital Management Co., Ltd.

SBI Investment Co., Ltd.

SBI Incubation Co., Ltd.

Trans-Science No. 2A Investment Limited Partnership

SBI Transscience Co., Ltd.

BIOVISION Life Science Fund No. 1

SBI Bio Life Science Investment LPS

SBI BB Mobile Investment LPS

SBI Phoenix No. 1 Investment LPS

The address for each Reporting Person is Izumi Garden Tower 19F, 1-6-1 Roppongi, Minato-ku, Tokyo 106-6019, Japan.

SBI Holdings, Inc., a corporation organized in Japan (“SBI Holdings”), is the parent company of the SBI Group, a financial services group in Japan.

The Common Stock is held directly by SBI Incubation Co., Ltd., BIOVISION Life Science Fund No. 1, SBI Bio Life Science Investment LPS, SBI BB Mobile Investment LPS, and SBI Phoenix No. 1 Investment LPS (collectively, the “Direct Holders”). Each is a corporation or private investment fund organized in Japan.

SBI Incubation Co., Ltd. is an indirect wholly-owned subsidiary of SBI Holdings.

SBI Transscience Co., Ltd., a private investment fund organized in Japan and a subsidiary of SBI Holdings is the sole general partner of Trans-Science No. 2A Investment Limited Partnership.

SBI Capital Management Co., Ltd., a corporation organized in Japan (“SBI Capital Management”), is a wholly-owned subsidiary of SBI Holdings.

SBI Investment Co., Ltd., a corporation organized in Japan (“SBI Investment”), is a wholly-owned subsidiary of SBI Capital Management.


SBI Investment is the sole general partner or the sole liquidator of BIOVISION Life Science Fund No. 1, SBI Bio Life Science Investment LPS, SBI BB Mobile Investment LPS, and SBI Phoenix No. 1 Investment LPS.

As a result of the Share Transfer, as defined in Item 3, SBI Transscience Co., Ltd. and Trans-Science No. 2A Investment Limited Partnership are no longer members of the Section 13(d) group and shall cease to be Reporting Persons immediately upon the filing of this Amendment.

Set forth on Schedule A hereto and incorporated herein by reference, is the name, business address, principal occupation, and citizenship of each of SBI Holdings’ directors and executive officers. In their capacity as directors or executive officers of SBI Holdings, each may be deemed a person controlling the Reporting Persons. Each of the Reporting Persons disclaims beneficial ownership of the Common Stock, except to the extent of such Reporting Person’s pecuniary interest therein.

During the past five years, none of the Reporting Persons, nor, to the knowledge of the Reporting Persons, any of the persons listed on Schedule A hereto, has been (i) convicted in a criminal proceeding (excluding traffic violations and similar misdemeanors), or (ii) a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.”

 

Item 3. Source and Amount of Funds or Other Consideration.

Item 3 of the Statement is hereby amended by adding the following paragraph to the end thereof:

“As of November 30, 2015, the 69,628 shares of Common Stock held by Trans-Science No. 2A Investment Limited Partnership were transferred to SBI Incubation Co., Ltd. (the “Share Transfer”) for consideration based on the closing market price of the Common Stock on the Tokyo Stock Exchange on November 30, 2015. The funds were provided from SBI Incubation Co., Ltd.’s available cash resources.”

 

Item 4. Purpose of Transaction.

Item 4 of the Statement is amended by (i) deleting the last paragraph, and (ii) adding the following paragraphs at the end thereof:

“On November 26, 2015, the Reporting Persons and the Issuer entered into the Registration Rights Agreement (the “Registration Rights Agreement”), as described in Item 6.

As of November 30, 2015, the 69,628 shares of Common Stock held by Trans-Science No. 2A Investment Limited Partnership were transferred to SBI Incubation Co., Ltd. in the Share Transfer. As a result of the Share Transfer, (i) SBI Transscience Co., Ltd., and (ii) Trans-Science No. 2A Investment Limited Partnership, over which SBI Transscience is the sole general partner, are no longer members of the Section 13(d) group.

Except as described herein, none of the Reporting Persons have present plans or proposals that relate to or would result in any of the actions described in Items 4(a) through (j) of Schedule 13D.”

 

Item 5. Interest in Securities of the Issuer.

Item 5(a), (b) and (c) of the Statement are hereby deleted and replaced with the following:

“(a), (b)


As of the date hereof, each of the Reporting Persons may be deemed to beneficially own the aggregate number of and percentage of Common Stock listed opposite its name:

 

Reporting Person    Amount
Beneficially
Owned1
     Percent of
Class2
    Sole power
to vote or
direct the
vote
     Shared
power to
vote or
direct the
vote
     Sole power
to dispose
or direct
the
disposition
of
     Shared
power to
dispose or
direct the
disposition
of
 

SBI Holdings, Inc.

     7,752,425         21.2     0         7,752,425         0         7,752,425   

SBI Capital Management Co., Ltd.

     6,196,869         17.0     0         6,196,869         0         6,196,869   

SBI Investment Co., Ltd.

     4,160,115         11.4     0         4,160,115         0         4,160,115   

SBI Incubation Co., Ltd.

     1,555,556         4.3     0         1,555,556         0         1,555,556   

Trans-Science No. 2A Investment Limited Partnership

     0         0        0         0         0         0   

SBI Transscience Co., Ltd.

     0         0        0         0         0         0   

BIOVISION Life Science Fund No.1

     1,777,778         4.9     0         1,777,778         0         1,777,778   

SBI Bio Life Science Investment LPS

     1,871,250         5.1     0         1,871,250         0         1,871,250   

SBI BB Mobile Investment LPS

     258,582         0.7     0         258,582         0         258,582   

SBI Phoenix No. 1 Investment LPS

     252,505         0.7     0         252,505         0         252,505   

 

1  Each of the Reporting Persons expressly disclaims beneficial ownership of the Common Stock, except to the extent of such Reporting Person’s pecuniary interest therein.
2  The percentage ownership is based upon 36,503,120 outstanding shares as reported by the Issuer in its FORM 10-Q filed with the Securities and Exchange Commission on November 13, 2015.


(c) Other than with respect to the Share Transfer, none of (i) the Reporting Persons and, (ii) to the Reporting Persons’ knowledge, the persons set forth on Schedule A hereto has effected any transaction in the Issuer’s Common Stock during the past 60 days.”

 

Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.

Item 6 of the Statement is hereby amended by the addition of the following information:

“On November 26, 2015, the Reporting Persons entered into the Registration Rights Agreement with the Issuer, pursuant to which the Reporting Persons became entitled to certain customary registration rights.

Under the Registration Rights Agreement, the Issuer agreed to file with the Securities and Exchange Commission a registration statement (the “Registration Statement”) to register under the Securities Act of 1933, as amended (the “Securities Act”), the resale of all 7,752,425 shares of the Issuer’s common stock held by the Reporting Persons.

The Issuer has agreed to use its commercially reasonable efforts to keep the Registration Statement continuously effective under the Securities Act until the earlier of: (i) the date on which all of the shares of the Issuer’s common stock subject to the Registration Statement have been publicly sold by the Reporting Persons, or (ii) the three year anniversary of the effective date of the Registration Statement. The Issuer may, under certain circumstances, suspend the availability of the Registration Statement for one or more periods not to exceed 45 consecutive days in any 90 day period and for an aggregate of 90 days in any 365 day period.

The foregoing description of the Registration Rights Agreement is not, and does not purport to be, complete and is qualified in its entirety by reference to the copy filed as Exhibit 7.5 and incorporated herein in its entirety by this reference.”

 

Item 7. Material to Be Filed as Exhibits.

Item 7 of the Statement is hereby amended by the addition of the following exhibit:

 

Exhibit
No.

  

Exhibit

7.5    Registration Rights Agreement, dated November 26, 2015 (incorporated by reference to Exhibit 10.1 to the Issuer’s Current Report on Form 8-K filed with the Securities and Exchange Commission on November 27, 2015).


SIGNATURE

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date: December 1, 2015

 

SBI HOLDINGS, INC.
By:  

/s/ Yoshitaka Kitao

Name:   Yoshitaka Kitao
Title:   Representative Director, President & CEO
SBI CAPITAL MANGEMENT CO., LTD.
SBI INVESTMENT CO., LTD.,
SBI INCUBATION CO., LTD.,
TRANS-SCIENCE NO. 2A INVESTMENT LIMITED PARTNERSHIP,
SBI TRANSSCIENCE CO., LTD.
BIOVISION LIFE SCIENCE FUND NO.1,
SBI BIO LIFE SCIENCE INVESTMENT LPS,
SBI BB MOBILE INVESTMENT LPS,
AND
SBI PHOENIX NO. 1 INVESTMENT LPS,
By:  

/s/ Katsuya Kawashima

Name:   Katsuya Kawashima
Title:   Authorized Signatory


SCHEDULE A

The business address of each director and executive officer is c/o SBI Holdings, Inc., Izumi Garden Tower 19F, 1-6-1 Roppongi, Minato-ku, Tokyo 106-6019, Japan. Each director and executive officer is a citizen of Japan except for Ayako Hirota Weissman, a citizen of the United States.

SBI HOLDINGS, INC. — BOARD OF DIRECTORS

 

Name

 

Title

  

Present Occupation

  

Present Business Address

Yoshitaka Kitao   Representative Director, President & CEO    Representative Director and Chairman of SBI Investment Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director and Chairman of SBI SECURITIES Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of Morningstar Japan K.K.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI Japannext Co., Ltd.    3-1-1 Roppongi, Minato-ku, Tokyo, Japan
     Director and Chairman of SBI FINANCIAL SERVICES Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director and Chairman of SBI Capital Management Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director & CEO of SBI Pharmaceuticals Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director and Chairman of SBI GLOBAL ASSET MANAGEMENT Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director of SBI Hong Kong Holdings Co., Limited    Room 806, 8/F, Tower Two, Lippo Centre, No.89 Queensway, Hong Kong
Katsuya Kawashima   Representative Director, Senior Executive Vice President & Co-COO    Director of SBI SECURITIES Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI FINANCIAL SERVICES Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director and President of SBI Capital Management Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director and President of SBI Investment Co., Ltd    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director of SBI Incubation Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director of SBI Transscience Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
Takashi Nakagawa   Representative Director, Senior Executive Vice President & Co-COO    Director of SBI Investment Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI Capital Management Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI Incubation Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI Transscience Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Chairman of the Board of Directors of SBI AXES Co., Ltd.    2-1-1 Shibuya, Shibuya-ku, Tokyo, Japan


     Representative Director and President of SBI FINANCIAL SERVICES Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director and Chairman of SBI MONEY PLAZA Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI SECURITIES Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
Tomoya Asakura   Director & Senior Managing Executive Officer    Representative Director & President of Morningstar Japan K.K.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI Insurance Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI FINANCIAL SERVICES Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director of Morningstar Asset Management Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Representative Director & President of SBI SSI Holdings Co., Ltd.    1-8-10 Kudankita, Chiyoda-ku, Tokyo, Japan
     Director of SBI Life Insurance Co., Ltd.    2-4-1, Nishishinjuku,Shinjuku-ku, Tokyo, Japan
     Representative Director, President & CEO of SBI GLOBAL ASSET MANAGEMENT Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI ENERGY Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
Shumpei Morita   Director, Managing Executive Officer & CFO    Representative Director and President of SBI Business Solutions Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI FINANCIAL SERVICES Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI Capital Management Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
     Director of SBI Incubation Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
Kazuhiro Nakatsuka  

Director, Managing Executive

Officer

   Representative Director of SBI ENERGY Co., Ltd.     1-6-1 Roppongi, Minato-ku, Tokyo, Japan
Masato Takamura   Director    Representative Director and President of SBI SECURITIES Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
Tatsuo Shigemitsu   Director    Representative Director and President of SBI Liquidity Market Co., Ltd.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
Masaki Yoshida   Director    Representative Director of YOSHIDAMASAKI INC.    4-2-27 Shibuya, Shibuya-ku, Tokyo, Japan
     Representative Director and Chairman of Watanabe Entertainment Co., Ltd.    4-2-12 Jingumae, Shibuya-ku, Tokyo, Japan


     Outside Director of KLab Inc.    6-10-1 Roppongi, Minato-ku, Tokyo, Japan
Kiyoshi Nagano   Outside Director    Outside Audit & Supervisory Board Member of Shin-Etsu Chemical Co., Ltd.    2-6-1 Otemachi, Chiyoda-ku, Tokyo, Japan
     Outside Director of LEC, INC.    3-15-1 Nihonbashi Hamacho, Chuo-ku, Tokyo, Japan
Keiji Watanabe   Outside Director    Independent Outside Director of ASAHI KOGYOSHA CO., LTD.    3-13-12 Mita, Minato-ku, Tokyo, Japan
     Outside Director of Aoyama Zaisan Networks Company, Limited    8-4-14 Akasaka, Minato-ku, Tokyo, Japan
Akihiro Tamaki   Outside Director    Representative Director of SiFA Co., Ltd.    1-22-19 Komaba, Meguro-ku, Tokyo, Japan
     External Corporate Auditor of Avex Group Holdings Inc.    1-6-1 Roppongi, Minato-ku, Tokyo, Japan
Masanao Marumono   Outside Director    Vice-President of Japan Association of Employers of Persons with Severe Disabilities    3-11-11 Hatchobori, Chuo-ku, Tokyo, Japan
     Counsel for SMBC Green Service Co., Ltd.    3-3-15 Nishi Ishikiricho, Higashi Osaka-shi, Osaka, Japan
Teruhide Sato   Outside Director    Komisaris of PT MIDTRANS   

Midplaza 2, 24th Floor Jl. Jend. Sudirman Kav. 10-11

Jakarta Pusat, 10220 Indonesia

     Director of BEENEXT PTE. LTD.   

1 RAFFLES PLACE #29-02

ONE RAFFLES PLACE SINGAPORE, 048616

Ayako Hirota Weissman   Outside Director    Senior Vice President, Senior Portfolio Manager, Director of Asia Strategy of Horizon Kinetics LLC    470 Park Avenue South New York NY 10016
Yasumine Satake   Outside Director    Chairperson of the board of directors of The Japan Opera Foundation (established as a public interest incorporated foundation) (a part-time position)    2-43-7 Uehara,Shibuya- Ku, Tokyo, Japan


SBI HOLDINGS, INC. — EXECUTIVE OFFICERS

 

Name

  

Title

Kenji Hirai    Executive Officer
Masayuki Yamada    Executive Officer
Hideo Nakamura    Executive Officer
Makoto Miyazaki    Executive Officer

Kazuhito Uchio

Hiroaki Morita

Motoaki Shiino

  

Executive Officer

Executive Officer

Executive Officer